Oseltamivir and Baloxavir Marboxil for Prophylaxis Against Influenza Under a Hospital-based Setting
Status:
NOT_YET_RECRUITING
Trial end date:
2025-05-05
Target enrollment:
Participant gender:
Summary
This study aims to randomly assign close contacts of hospitalized influenza virus patients to receive baloxavir marboxil prophylaxis, oseltamivir prophylaxis or no antiviral prophylaxis and monitor the incidence of clinical influenza, evaluating the prophylaxis efficiency of antivirals in a hospital setting.
Phase:
NA
Details
Lead Sponsor:
Capital Medical University
Collaborators:
China-Japan Friendship Hospital Chinese Academy of Medical Sciences